Wörwag Pharma Beteiligung GmbH

DEB8534.HRB17799|Flugfeld-Allee 24, 71034 BöblingenGermany|1996

Profit€43.3M

Revenue€328.7M

Employees1.5K

Balance€403.3M

About

Mittelständisches Pharmaunternehmen mit Fokus auf Produktion, Vermarktung und Vertrieb von Arzneimitteln, insbesondere in den Bereichen Biofaktoren und Generika. Wörwag Pharma Beteiligung GmbH is a family business.

Business purpose (commercial register)

Die Beteiligung an Industrie- und Handelsunternehmen, insbesondere die Beteiligung als Kommanditistin an der Kommanditgesellschaft unter der Firma Wörwag Pharma GmbH & Co. KG mit dem Sitz in Böblingen.

ClassificationWZ 2025

No. 968 of 1,387 – Top Employers with 1,000+ Staff L.64.21.0 - Beteiligungsgesellschaften

Network

Levels

CompanyPersonShareholdingOfficer or Prokura

Business Sectors

Generika16.407 TEUR(5.0%)

Biofaktoren312.292 TEUR(95.0%)

Products

Arzneimittel Vitamine Mineralien Spurenelemente Biologie

Opportunities & Risks

Wachstum Digitalisierung Marke Produktion Vertrieb Pharma Innovation Internationalisierung

Währung Regulatorische Anforderungen Wettbewerbsdruck Lieferketten Geopolitische Risiken IT-Sicherheit Haftungsrisiken Konjunkturrisiken

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 17799 (as of 25 September 2026)

Company Structure

Shareholders

Name	Type	City
Marcus Wörwag	Geschäftsführer(in)	Stuttgart
Monika Wörwag	Geschäftsführer(in)	Stuttgart

Company	Location
FIBEG Immobilien GmbH	Böblingen
Wörwag Pharma GmbH & Co. KG	Böblingen
Wörwag Pharma Production GmbH & Co. KG	Pöcking

Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 17799 (as of 25 September 2026)

Company History

Management

Date	Event Type	Event
27.01.2026	Registered Seat Change	Böblingen
27.01.2026	Gesellschaftsvertrag amended	Gesellschaftsvertrag
29.11.2021	Business Address Change	Flugfeld-Allee 24, 71034 Böblingen

Date	Type	Change	Total Capital
27.01.2026	Capital Increase	+1.000 €	105.000 €
18.10.2005	Share Capital Set	—	104.000 €

Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 17799 (as of 25 September 2026)

Financials

Key financial figures over time — Wörwag Pharma Beteiligung GmbH
Year	Revenue	Profit	Balance	Employees
2024	€328,699,146	€43,269,157	€403,305,585	1,477
2023	€295,359,120	€30,395,857	€354,305,241	1,368
2022	€285,905,865	€30,573,999	€311,652,024	1,195
2021	€262,922,386	€56,580,042	€310,703,308	1,185
2020	€227,666,220	€27,085,392	€243,372,498	1,013
2019	€227,274,994	€34,291,075	€229,475,487	956
2018	€206,457,400	€22,750,170	€193,975,935	—
2017	€194,318,176	€21,100,551	€186,040,035	—
2016	€182,301,749	€30,086,331	€159,883,120	—
2015	€188,127,529	€13,222,341	€146,399,604	—

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

List of ShareholdersPublished on 20 February 2026

Articles of Association

Registration Application

Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 17799 (as of 25 September 2026)

Contact

Group website:woerwagpharma.devia Wörwag Pharma

Email:Sign in to view

Similar Companies

OSI Holding Germany GmbH

Augsburg · Beteiligungsgesellschaften

€299.3M

Orizon Holding GmbH

Augsburg · Beteiligungsgesellschaften

€3.5M

Lambertz Beteiligungs GmbH

Aachen · Beteiligungsgesellschaften

Annual Financial Statements

Annual Report 2024Published on 20 January 2026

Consolidated Report 2024Published on 19 November 2025

Consolidated Report 2023Published on 3 February 2025

Annual Report 2023Published on 16 January 2025

Annual Report 2022Published on 16 January 2024

Consolidated Report 2022Published on 21 December 2023

Annual Report 2021Published on 24 January 2023

Consolidated Report 2021Published on 15 December 2022

Consolidated Report 2020Published on 13 December 2021

Annual Report 2020Published on 23 November 2021

Annual Report 2019Published on 11 February 2021

Consolidated Report 2019Published on 1 February 2021

Annual Report 2018Published on 17 January 2020

Consolidated Report 2018Published on 23 December 2019

Consolidated Report 2017Published on 18 December 2018

Annual Report 2017Published on 17 December 2018

Annual Report 2016Published on 30 January 2018

Consolidated Report 2016Published on 25 January 2018

Consolidated Report 2015Published on 27 January 2017

Annual Report 2015Published on 29 December 2016

Consolidated Report 2014Published on 26 November 2015

Annual Report 2014Published on 6 November 2015

Consolidated Report 2013Published on 21 May 2015

Annual Report 2013Published on 9 March 2015

Consolidated Report 2012Published on 7 February 2014

Annual Report 2012Published on 3 February 2014

Annual Report 2011Published on 29 July 2013

Consolidated Report 2011Published on 5 March 2013

Consolidated Report 2010Published on 13 April 2012

Annual Report 2010Published on 6 July 2011

Consolidated Report 2009Published on 21 March 2011

Consolidated Report 2008Published on 20 July 2010

Annual Report 2008Published on 11 December 2009

Annual Report 2007Published on 14 January 2009

Annual Report 2006Published on 28 May 2008

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Personnel Costs	€77,215,001	20.8%
Material Costs	€280,750,237	75.7%
Depreciation	€8,492,029	2.3%
Interest & Similar	€4,403,785	1.2%

Wörwag Pharma Beteiligung GmbH

About

Business purpose (commercial register)

ClassificationWZ 2025

Network

Business Sectors

Products

Opportunities & Risks

Company Structure

Company History

Financials

Register Files

Contact

Similar Companies

Annual Financial Statements

Cost Distribution (2024)